🧠Cognitive Enhancement

An oligopeptide derived from angiotensin IV that is reported to be 10 million times more potent than BDNF at enhancing cognitive function through hepatocyte growth factor (HGF) signaling.

A naturally occurring anti-inflammatory tripeptide derived from the C-terminal end of alpha-melanocyte-stimulating hormone (α-MSH), studied for its potent anti-inflammatory effects in the gut, skin, and systemically.

A D-retro-inverso peptide that selectively induces apoptosis in senescent cells by disrupting the FOXO4-p53 interaction, representing a targeted senolytic approach to aging.

The only human cathelicidin antimicrobial peptide, a 37-amino acid peptide beginning with two leucines, with broad-spectrum antimicrobial, anti-biofilm, immunomodulatory, and wound healing properties.

A porcine brain-derived peptide preparation containing low-molecular-weight neuropeptides and free amino acids, used clinically in many countries for stroke recovery, traumatic brain injury, and dementia.

A mitochondria-targeted tetrapeptide that concentrates in the inner mitochondrial membrane, protecting cardiolipin and restoring bioenergetics in aging and disease.

A mitochondria-derived peptide that acts as an exercise mimetic, improving metabolic health, insulin sensitivity, and physical performance through AMPK activation.

A small synthetic peptide derived from ciliary neurotrophic factor (CNTF) that promotes neurogenesis and enhances cognitive function by inhibiting leukemia inhibitory factor (LIF) signaling.

A mitochondria-derived 24-amino acid peptide with potent cytoprotective and neuroprotective effects, being studied for Alzheimer's disease, metabolic health, and longevity.

A heptapeptide fragment of adrenocorticotropic hormone that enhances memory, attention, and learning without the adrenal-stimulating effects of full-length ACTH, serving as the basis for nootropic peptides like Semax.

An experimental nootropic peptide investigated for cognitive enhancement, neuroprotection, and memory improvement, derived from research into growth hormone fragments and neural signaling.

A 28-amino acid thymic peptide that modulates immune function, approved in multiple countries for hepatitis B and used as an immune enhancer in cancer and infectious disease.

A synthetic tetrapeptide based on the natural epithalamin peptide from the pineal gland, studied for its ability to activate telomerase and potentially slow cellular aging.

A 9-amino acid neuropeptide hormone involved in social bonding, trust, stress reduction, and sexual function, with emerging research in autism spectrum disorders and anxiety.

A class of molecules that boost cellular NAD+ levels to support energy metabolism, DNA repair, sirtuin activation, and anti-aging pathways — while not peptides themselves, they are commonly discussed alongside anti-aging peptides.

A synthetic hexapeptide growth hormone secretagogue considered to offer the best balance of potency and side effect profile among the GHRP family.

A synthetic heptapeptide derived from ACTH(4-10) with a Pro-Gly-Pro C-terminal extension, used as a nootropic and neuroprotectant with regulatory approval in Russia for stroke and cognitive disorders.

An 11-amino acid synthetic peptide derived from erythropoietin (EPO) that promotes tissue repair and neuroprotection without stimulating red blood cell production.

A 36-amino acid neuropeptide abundantly expressed in the brain and sympathetic nervous system that regulates appetite, stress resilience, anxiety, and energy homeostasis.

A synthetic hexapeptide growth hormone secretagogue that potently stimulates GH release through the ghrelin receptor, with additional cardioprotective properties.

A synthetic heptapeptide anxiolytic derived from the endogenous immunomodulatory peptide tuftsin, with an added Pro-Gly-Pro C-terminus, approved in Russia for anxiety and neurasthenia.

A naturally occurring dipeptide of beta-alanine and histidine found in high concentrations in muscle and brain tissue, with antioxidant, anti-glycation, and anti-aging properties.

A class of ultra-short (2-4 amino acid) tissue-specific peptides developed by Prof. Vladimir Khavinson that regulate gene expression in target organs, used in Russian medicine for anti-aging and organ-specific rejuvenation.

An 11-amino acid neuropeptide involved in pain transmission, inflammation, and emotional stress responses, primarily acting through the neurokinin-1 (NK1) receptor.

A 15-amino acid synthetic peptide derived from human gastric juice that promotes healing of tendons, ligaments, muscles, gut lining, and other tissues through multiple regenerative pathways.

An investigational triple-agonist peptide targeting GLP-1, GIP, and glucagon receptors, producing unprecedented weight loss of up to 24% in clinical trials.

The arginine salt form of BPC-157, optimized for oral bioavailability and stability, used interchangeably with BPC-157 for tissue healing and gut repair.

An investigational dual glucagon and GLP-1 receptor agonist being developed for obesity and MASH (metabolic dysfunction-associated steatohepatitis) with significant liver fat reduction.

A naturally occurring nonapeptide that promotes delta-wave deep sleep, modulates stress hormones, and has potential applications in insomnia, pain, and withdrawal syndromes.

A 28-amino acid neuropeptide with broad immunomodulatory, vasodilatory, and anti-inflammatory effects, used in CIRS (Chronic Inflammatory Response Syndrome) protocols and researched for pulmonary conditions.

An FDA-approved GLP-1 receptor agonist used for type 2 diabetes and chronic weight management, producing significant weight loss of 15-17% body weight in clinical trials.

An FDA-approved GLP-1 receptor agonist used for type 2 diabetes and obesity management, with cardiovascular and neuroprotective benefits.

An FDA-approved once-weekly GLP-1 receptor agonist for type 2 diabetes with proven cardiovascular benefits and convenient single-use pen delivery.

The first GLP-1 receptor agonist approved for type 2 diabetes, originally derived from Gila monster venom, available in twice-daily and once-weekly formulations.

A 9-amino acid endogenous peptide hormone produced in the hypothalamus that regulates water retention, blood pressure, and social behavior through V1 and V2 receptor activation.

A triple monoamine reuptake inhibitor (serotonin, norepinephrine, dopamine) originally developed for Parkinson's and Alzheimer's disease, repurposed as a potent weight-loss agent.